MetaCap

Neogen Statistics

NASDAQ: NEOGHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

10.55-0.30 (-2.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Neogen by the numbers

Neogen has a market capitalization of $2.30 billion based on 218.31M shares outstanding. With trailing EPS of $-0.26, Neogen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.1% below its 50-day average and 0.2% above its 200-day average.

Average daily trading volume is 3.53M shares, or about $37.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NEOG valuation vs. peer median

NEOG compared with the median of 8 peer companies
MetricNEOGPeer medianDifference
Market cap$2.30B$547.30M+321%
Avg. volume3.53M1.36M+159%

Peer median across 8 companies: CLDX, NTLA, QUIT, QDEL, MYGN, TKNO, NNNN, ICCC.

Valuation

Price / sales (latest FY)
2.65
EPS (TTM)
$-0.26

Price and trading

Previous close
10.85
Open
10.76
Day range
10.42 – 10.94
52-week range
5.60 – 14.26
52-week change
+84.44%
Beta
—
Volume
3.04M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
2.30B
Forward Pe
23.44
Eps
-0.26
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
14.26
Week52 Low
5.60
Avg Volume
3.53M
Shares Outstanding
218.31M
Ma50
12.14
Ma200
10.53
Earnings Date
Oct 6, 2026
Pct From52w High
-26.02%
Pct From52w Low
88.39%

Related